In BC, several serum tumor biomarkers have been proposed, including the MUC-1 antigen (CA 15-3), the onco-fetal protein carcinoembryonic antigen (CEA), the oncoprotein HER-2/neu, and the cytokeratin tissue polypeptide specific antigen (TPS). Here, ERBB2 is linked to neoplasm.